Why is Infinium Pharma falling/rising?

As of 11-Nov, Infinium Pharmachem Ltd is experiencing a price increase, currently at 269.40, reflecting a rise of 9.4 or 3.62%. The stock has shown positive performance today, outperforming its sector by 3.9%. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. However, there is a notable decline in investor participation, with delivery volume dropping by 93.79% compared to the 5-day average. Over the past week, the stock has gained 2.05%, and over the past month, it has risen by 5.03%, although it remains down 10.17% year-to-date and 18.82% over the past year.
In the broader market context, the Sensex has increased by 0.38% over the past week and 1.62% over the past month, indicating that Infinium's short-term performance is significantly better than the benchmark. Despite the stock's recent gains, its year-to-date and one-year returns are negative, contrasting with the Sensex's positive performance of 8.67% and 6.44%, respectively. This suggests that while Infinium is currently rising, it has struggled over a longer time frame compared to the overall market.